A pilot phase IV open label study investigating the safety...

Alzheimer's & Dementia 2011 / 07 Vol. 7; Iss. 4

A pilot phase IV open label study investigating the safety and tolerability of switching from the Exelon patch 9.5mg daily to Aricept 23mg daily in patients with moderate to severe AD

Sabbagh, Marwan, Syal, Atul, Obradov, Zoran, Kahlon, Maninder, Jacobson, Sandra, Shah, Jatin, Liebsack, Carolyn, Belden, Christine, Shutts, Tammy, Malek-Ahmadi, Michael, Kratz, Kris, Klinck, Brian
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2011.09.131
Date:
July, 2011
File:
PDF, 51 KB
english, 2011
Conversion to is in progress
Conversion to is failed